Largest biotechnology: biological products (no diagnostic substances) companies — Page 2
Every US-listed biotechnology: biological products (no diagnostic substances) company we cover, 162 of them, ranked by market capitalisation, with revenue and earnings taken from their SEC filings.
Combined market cap
$909.588 B
0.9% of all US-listed value
Companies
162
Ranked #22 of 152 industries
Average
$5.615 B
Mean market cap per company
| # | Name | Market cap | Close | Session | Country |
|---|---|---|---|---|---|
| 101 | Acumen PharmaceuticalsABOS | $146.8M | $2.03 | +0.74% | United States |
| 102 | Compass TherapeuticsCMPX | $146.7M | $0.81 | -2.26% | United States |
| 103 | Cardiol TherapeuticsCRDL | $141.2M | $1.17 | +1.74% | Canada |
| 104 | Molecular PartnersMOLN | $139.5M | $3.72 | +0.54% | Switzerland |
| 105 | Outlook TherapeuticsOTLK | $136.6M | $0.56 | +7.94% | United States |
| 106 | Anavex Life SciencesAVXL | $126.1M | $1.36 | +0.00% | United States |
| 107 | Voyager TherapeuticsVYGR | $124.5M | $2.02 | -7.76% | United States |
| 108 | Black Diamond TherapeuticsBDTX | $119.5M | $2.08 | +0.48% | United States |
| 109 | HumacyteHUMA | $114.2M | $0.41 | +1.28% | United States |
| 110 | Armata PharmaceuticalsARMP | $113.8M | $3.06 | -4.38% | United States |
| 111 | enGene TherapeuticsENGN | $109.2M | $1.63 | -2.40% | Canada |
| 112 | TevogenTVGN | $101.3M | $6.44 | -5.57% | United States |
| 113 | LENZ TherapeuticsLENZ | $101.2M | $3.22 | +0.94% | United States |
| 114 | Atara BiotherapeuticsATRA | $93.9M | $9.35 | +2.07% | United States |
| 115 | Tenaya TherapeuticsTNYA | $88.9M | $0.39 | -4.83% | United States |
| 116 | Greenland MinesGRML | $82.6M | $6.19 | -0.16% | United States |
| 117 | OKYO PharmaOKYO | $80.8M | $1.54 | +12.41% | Guernsey |
| 118 | Neumora TherapeuticsNMRA | $78.2M | $0.42 | -10.54% | United States |
| 119 | Cardiff OncologyCRDF | $73.0M | $0.94 | +0.80% | United States |
| 120 | Pelthos TherapeuticsPTHS | $71.6M | $18.70 | -8.78% | United States |
| 121 | Cognition TherapeuticsCGTX | $71.0M | $0.75 | +1.74% | United States |
| 122 | Champions OncologyCSBR | $67.5M | $4.85 | +0.83% | United States |
| 123 | Caribou BiosciencesCRBU | $58.4M | $0.54 | +4.89% | United States |
| 124 | MiNK TherapeuticsINKT | $54.2M | $10.62 | +7.71% | United States |
| 125 | Eloxx PharmaceuticalsELOX | $53.7M | $13.30 | +0.60% | United States |
| 126 | LeonaBioLONA | $53.4M | $5.67 | +7.59% | United States |
| 127 | Kalaris TherapeuticsKLRS | $48.1M | $2.02 | -2.42% | United States |
| 128 | ImageneBioIMA | $46.4M | $4.09 | -1.09% | United States |
| 129 | Inmune BioINMB | $44.7M | $1.61 | +0.63% | United States |
| 130 | Instil BioTIL | $39.1M | $5.77 | -2.86% | United States |
| 131 | ExozymesEXOZ | $36.5M | $3.92 | -4.85% | United States |
| 132 | ElutiaELUT | $36.4M | $0.82 | +1.52% | United States |
| 133 | Evaxion A/SEVAX | $33.5M | $3.71 | -8.39% | Denmark |
| 134 | BioStem TechnologiesBSEM | $31.4M | $1.68 | +2.44% | United States |
| 135 | Metagenomi TherapeuticsMGX | $31.3M | $0.83 | -0.30% | United States |
| 136 | Aligos TherapeuticsALGS | $31.0M | $4.96 | -1.39% | United States |
| 137 | Genenta Science S.p.A.GNTA | $30.9M | $0.64 | +4.07% | Italy |
| 138 | Cel SciCVM | $28.5M | $1.62 | +4.52% | United States |
| 139 | Estrella ImmunopharmaESLA | $23.9M | $0.55 | +37.50% | United States |
| 140 | ScilexSCLX | $21.7M | $2.56 | +1.19% | United States |
| 141 | Black Hawk AcquisitionBKHA | $20.4M | $4.90 | +18.36% | United States |
| 142 | Atyr PharmaATYR | $16.9M | $0.17 | -0.58% | United States |
| 143 | Jasper TherapeuticsJSPR | $16.8M | $0.50 | +0.88% | United States |
| 144 | Dyadic InternationalDYAI | $16.0M | $0.40 | +3.87% | United States |
| 145 | BioCardiaBCDA | $14.9M | $0.98 | -5.54% | United States |
| 146 | TScan TherapeuticsTCRX | $14.2M | $0.22 | +0.00% | United States |
| 147 | PluriPLUR | $14.1M | $1.05 | +16.67% | Israel |
| 148 | Passage BIOPASG | $11.6M | $3.59 | -0.28% | United States |
| 149 | In8bioINAB | $10.7M | $1.09 | -4.39% | United States |
| 150 | Intensity TherapeuticsINTS | $10.3M | $3.14 | -4.19% | United States |
| 151 | AIM ImmunoTechAIM | $6.78M | $0.17 | +2.29% | United States |
| 152 | Senti BiosciencesSNTI | $6.77M | $0.22 | -4.48% | United States |
| 153 | Black TitanBTTC | $5.76M | $0.38 | +4.24% | Malaysia |
| 154 | Creative Medical TechnologyCELZ | $5.64M | $0.74 | -1.63% | United States |
| 155 | Tessera Defense & Homeland SecurityHLSQ | $4.94M | $0.24 | +2.35% | United States |
| 156 | Liminatus PharmaLIMN | $4.19M | $3.12 | -3.11% | United States |
| 157 | PharmaCyte BiotechPMCB | $3.73M | $0.35 | +1.49% | United States |
| 158 | VivoSim LabsVIVS | $2.94M | $0.18 | +3.33% | United States |
| 159 | Calidi BiotherapeuticsCLDI | $2.83M | $0.77 | -0.26% | United States |
| 160 | Silexion TherapeuticsSLXN | $2.39M | $0.17 | +7.28% | Israel |
| 161 | Scinai ImmunotherapeuticsSCNI | $2.33M | $0.61 | -10.44% | Israel |
| 162 | CurisCRIS | $1.61M | $0.39 | -1.90% | United States |
Showing 101–162 of 162 companies. One row per company, with secondary share classes folded into their primary listing. Updated 23 Oct 2026.
Sectors biotechnology: biological products (no diagnostic substances) companies sit in
Other industries
Semiconductors 100Computer Software: Programming Data Processing 77Computer Software: Prepackaged Software 233Computer Manufacturing 10Biotechnology: Pharmaceutical Preparations 500Major Banks 243Industrial Machinery/Components 210Catalog/Specialty Distribution 30Business Services 92Commercial Banks 35Integrated oil Companies 16Auto Manufacturing 29Oil & Gas Production 116Investment Bankers/Brokers/Service 69Department/Specialty Retail Stores 13Real Estate Investment Trusts 175Beverages (Production/Distribution) 36Telecommunications Equipment 84Electric Utilities: Central 61Finance: Consumer Services 165Electronic Components 20Medical Specialities 44Consumer Electronics/Appliances 23Property-Casualty Insurers 68All industries →
Figures come from SEC filings and daily market prices. Companies listed only outside the US are not covered: see methodology.